Search hospitals > Maryland > Bethesda
Walter Reed National Military Medical Center
Claim this profileBethesda, Maryland 20814
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
455 reported clinical trials
35 medical researchers
Summary
Walter Reed National Military Medical Center is a medical facility located in Bethesda, Maryland. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Breast cancer, Ovarian Cancer and other specialties. Walter Reed National Military Medical Center is involved with conducting 455 clinical trials across 722 conditions. There are 35 research doctors associated with this hospital, such as Rebecca O. Clark, Allen I. Stering, Jeremy Perkins, and Matthew Miller, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
ER negative
2Cancer
Global LeaderStage IV
Stage I
KRAS positive
Top PIs
Rebecca O. ClarkWalter Reed National Military Medical Center4 years of reported clinical research
Studies Brain Tumor
Studies Cancer
23 reported clinical trials
69 drugs studied
Allen I. SteringWalter Reed National Military Medical Center5 years of reported clinical research
Studies Brain Cancer
Studies Brain Tumor
18 reported clinical trials
57 drugs studied
Jeremy PerkinsWalter Reed National Military Medical Center3 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
15 drugs studied
Matthew Miller, MDDoernbecher Children's Hospital Oregon Health & Science University4 years of reported clinical research
Studies Brain Tumor
Studies Brain Cancer
6 reported clinical trials
14 drugs studied
Clinical Trials running at Walter Reed National Military Medical Center
Ovarian Cancer
Lung Cancer
Cancer
Breast Cancer
Breast cancer
Uterine Cancer
Testicular cancer
Lymphoma
Prostate Cancer
Neuroblastoma
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting2 awards Phase 34 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Walter Reed National Military Medical Center?
Walter Reed National Military Medical Center is a medical facility located in Bethesda, Maryland. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Breast cancer, Ovarian Cancer and other specialties. Walter Reed National Military Medical Center is involved with conducting 455 clinical trials across 722 conditions. There are 35 research doctors associated with this hospital, such as Rebecca O. Clark, Allen I. Stering, Jeremy Perkins, and Matthew Miller, MD.
Where is Walter Reed National Military Medical Center located?
**Directions to Walter Reed National Military Medical Center:**
- From I-495 North, the Capital Beltway, take Exit 34, Rt. 355 South, Wisconsin Ave., towards Bethesda.
- Turn left at the first median crossing (at the light) to enter Naval Support Activity Bethesda, where the medical center is located.
- Display your ID at the guard station to gain entry.
Who should I call to ask about financial aid or insurance network?
**Walter Reed National Military Medical Center Financial Assistance Information:**
- **Personal Financial Management Services:** Contact at (301) 319-4087 for financial assistance.
- **Military and Family Support Center:** Located at 9045 Beale Road, Building #11, Room 111, Bethesda, MD, United States 20889-0000.
- **Insurance Inquiries:** Visit the Naval Support Activity Bethesda Home of Walter Reed National Military Medical Center's website or the Tricare directory.
- **Emergency Financial Assistance:** Contact Army Emergency Relief (AER) at assistance@aerhq.org or call 1-866-878-6378 (Toll Free). Local AER office at Walter Reed can be reached at 301-400-0171 (V).
What insurance does Walter Reed National Military Medical Center accept?
The Walter Reed National Military Medical Center accepts various insurance plans, focusing on those under the TRICARE program, including TRICARE Prime, TRICARE Select, TRICARE For Life, TRICARE Reserve Select, and TRICARE Retired Reserve, as well as Johns Hopkins/US Family Health Plan (TRICARE PRIME ONLY). For non-TRICARE plans, the hospital is part of the Riverside Health System, accepting major carriers like Aetna, Anthem Blue Cross and Blue Shield, Cigna, and more, alongside Medicare Advantage Networks and Medicaid - Medallion 4.0 and CCC Plus Programs. Coverage and benefits may vary, so contacting your insurance provider directly is advised to confirm coverage details and potential costs.
What awards or recognition has Walter Reed National Military Medical Center received?
Walter Reed National Military Medical Center, located in Bethesda, Maryland, is renowned for its significant contributions to medical research, including the identification of potential drug candidates for sepsis. This institution, along with the Walter Reed Army Institute of Research (WRAIR), has been acknowledged through various awards for its dedication to advancing the field of medicine.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.